O	0	7	Vitamin	Vitamin	NN	B-NP
O	8	9	E	E	NN	I-NP
O	10	18	inhibits	inhibit	VBZ	B-VP
O	19	31	experimental	experimental	JJ	B-NP
O	32	46	carcinogenesis	carcinogenesis	NN	I-NP
O	47	50	and	and	CC	I-NP
B-Cancer	51	57	tumour	tumour	NN	I-NP
O	58	70	angiogenesis	angiogenesis	NN	I-NP
O	70	71	.	.	.	O

O	73	75	In	In	IN	B-PP
O	76	78	an	an	DT	B-NP
O	79	89	experiment	experiment	NN	I-NP
O	90	92	in	in	IN	B-PP
O	93	98	which	which	WDT	B-NP
O	99	106	vitamin	vitamin	NN	B-NP
O	107	108	E	E	NN	I-NP
O	109	118	inhibited	inhibit	VBD	B-VP
O	119	133	carcinogenesis	carcinogenesis	NN	B-NP
O	133	134	,	,	,	O
O	135	137	it	it	PRP	B-NP
O	138	141	was	be	VBD	B-VP
O	142	147	found	find	VBN	I-VP
O	148	152	that	that	IN	B-SBAR
B-Cancer	153	159	tumour	tumour	NN	B-NP
O	160	172	angiogenesis	angiogenesis	NN	I-NP
O	173	176	and	and	CC	O
O	177	183	tumour	tumour	NN	B-NP
O	184	190	growth	growth	NN	I-NP
O	190	191	-	-	HYPH	O
O	191	197	factor	factor	NN	B-NP
O	198	203	alpha	alpha	NN	I-NP
O	204	205	(	(	(	O
O	205	208	TGF	TGF	NN	B-NP
O	209	214	alpha	alpha	SYM	O
O	214	215	)	)	)	O
O	216	226	expression	expression	NN	B-NP
O	227	231	were	be	VBD	B-VP
O	232	236	also	also	RB	I-VP
O	237	246	inhibited	inhibit	VBN	I-VP
O	246	247	.	.	.	O

O	248	253	Forty	Forty	CD	B-NP
O	254	258	male	male	JJ	I-NP
O	259	265	golden	golden	JJ	I-NP
O	266	274	hamsters	hamster	NNS	I-NP
O	275	279	were	be	VBD	B-VP
O	280	287	divided	divide	VBN	I-VP
O	288	292	into	into	IN	B-PP
O	293	297	four	four	CD	B-NP
O	298	303	equal	equal	JJ	I-NP
O	304	310	groups	group	NNS	I-NP
O	310	311	.	.	.	O

O	312	317	Group	Group	NN	B-NP
O	318	319	1	1	CD	I-NP
O	320	327	animals	animal	NNS	I-NP
O	328	331	had	have	VBD	B-VP
O	332	335	the	the	DT	B-NP
B-Organism_subdivision	336	340	left	left	JJ	I-NP
I-Organism_subdivision	341	347	buccal	buccal	JJ	I-NP
I-Organism_subdivision	348	355	pouches	pouch	NNS	I-NP
O	356	363	painted	paint	VBD	B-VP
O	364	369	three	three	CD	B-NP
O	370	375	times	time	NNS	I-NP
O	376	382	weekly	weekly	RB	B-ADVP
O	383	387	with	with	IN	B-PP
O	388	389	7	7	CD	B-NP
O	389	390	,	,	,	I-NP
O	390	392	12	12	CD	I-NP
O	392	393	-	-	HYPH	I-NP
O	393	405	dimethylbenz	dimethylbenz	NN	I-NP
O	405	406	(	(	(	O
O	406	407	a	a	DT	O
O	407	408	)	)	)	O
O	408	418	anthracene	anthracene	NN	B-NP
O	419	420	(	(	(	O
O	420	424	DMBA	DMBA	NN	B-NP
O	424	425	)	)	)	O
O	426	429	for	for	IN	B-PP
O	430	432	14	14	CD	B-NP
O	433	438	weeks	week	NNS	I-NP
O	438	439	.	.	.	O

O	440	445	Group	Group	NN	B-NP
O	446	447	2	2	CD	I-NP
O	448	455	animals	animal	NNS	I-NP
O	456	459	had	have	VBD	B-VP
O	460	463	the	the	DT	B-NP
O	464	468	same	same	JJ	I-NP
O	469	478	procedure	procedure	NN	I-NP
O	479	481	of	of	IN	B-PP
O	482	486	DMBA	DMBA	NN	B-NP
O	487	499	applications	application	NNS	I-NP
O	500	503	but	but	CC	O
O	504	508	also	also	RB	B-VP
O	509	517	received	receive	VBD	I-VP
O	518	523	alpha	alpha	NN	B-NP
O	524	534	tocopherol	tocopherol	NN	I-NP
O	534	535	.	.	.	O

O	536	542	Groups	Group	NNS	B-NP
O	543	544	3	3	CD	I-NP
O	545	548	and	and	CC	I-NP
O	549	550	4	4	CD	I-NP
O	551	555	were	be	VBD	B-VP
O	556	563	vitamin	vitamin	NN	B-NP
O	564	565	E	E	NN	I-NP
O	566	569	and	and	CC	O
O	570	579	untreated	untreated	JJ	B-NP
O	580	588	controls	control	NNS	I-NP
O	588	589	.	.	.	O

O	590	602	Angiogenesis	Angiogenesis	NN	B-NP
O	603	606	was	be	VBD	B-VP
O	607	614	studied	study	VBN	I-VP
O	615	619	with	with	IN	B-PP
O	620	626	factor	factor	NN	B-NP
O	627	628	8	8	CD	I-NP
O	628	629	-	-	HYPH	I-NP
O	629	636	related	relate	VBN	I-NP
O	637	644	antigen	antigen	NN	I-NP
O	645	646	(	(	(	O
O	646	648	F8	F8	NN	B-NP
O	648	649	-	-	HYPH	B-NP
O	649	651	RA	RA	NN	I-NP
O	651	652	)	)	)	O
O	653	658	which	which	WDT	B-NP
O	659	669	identifies	identify	VBZ	B-VP
B-Cell	670	681	endothelial	endothelial	JJ	B-NP
I-Cell	682	687	cells	cell	NNS	I-NP
O	687	688	.	.	.	O

O	689	692	TGF	TGF	NN	B-NP
O	693	698	alpha	alpha	SYM	B-NP
O	699	702	was	be	VBD	B-VP
O	703	710	studied	study	VBN	I-VP
O	711	715	with	with	IN	B-PP
O	716	719	the	the	DT	B-NP
O	720	731	appropriate	appropriate	JJ	I-NP
O	732	740	antibody	antibody	NN	I-NP
O	740	741	.	.	.	O

O	742	750	Staining	Staining	NN	B-NP
O	751	754	was	be	VBD	B-VP
O	755	763	effected	effect	VBN	I-VP
O	764	766	by	by	IN	B-PP
O	767	770	the	the	DT	B-NP
O	771	779	standard	standard	JJ	I-NP
O	780	786	avidin	avidin	NN	I-NP
O	786	787	-	-	HYPH	B-NP
O	787	793	biotin	biotin	NN	I-NP
O	794	805	horseradish	horseradish	NN	I-NP
O	806	816	peroxidase	peroxidase	NN	I-NP
O	817	823	system	system	NN	I-NP
O	823	824	.	.	.	O

O	825	829	Mean	Mean	JJ	B-NP
B-Cancer	830	836	tumour	tumour	NN	I-NP
O	837	843	volume	volume	NN	I-NP
O	844	847	was	be	VBD	B-VP
O	848	861	significantly	significantly	RB	B-ADJP
O	862	867	lower	low	JJR	I-ADJP
O	868	870	in	in	IN	B-PP
O	871	874	the	the	DT	B-NP
O	875	879	DMBA	DMBA	NN	I-NP
O	879	880	-	-	HYPH	B-NP
O	880	887	vitamin	vitamin	NN	I-NP
O	888	889	E	E	NN	I-NP
O	890	895	group	group	NN	I-NP
O	896	904	compared	compare	VBN	B-VP
O	905	907	to	to	TO	B-PP
O	908	911	the	the	DT	B-NP
B-Cancer	912	918	tumour	tumour	NN	I-NP
O	919	926	control	control	NN	I-NP
O	927	932	group	group	NN	I-NP
O	932	933	.	.	.	O

O	934	946	Angiogenesis	Angiogenesis	NN	B-NP
O	947	950	was	be	VBD	B-VP
O	951	964	significantly	significantly	RB	I-VP
O	965	974	inhibited	inhibit	VBN	I-VP
O	975	977	in	in	IN	B-PP
O	978	981	the	the	DT	B-NP
O	982	986	DMBA	DMBA	NN	I-NP
O	986	987	-	-	HYPH	B-NP
O	987	994	vitamin	vitamin	NN	I-NP
O	995	996	E	E	NN	I-NP
O	997	1002	group	group	NN	I-NP
O	1003	1006	and	and	CC	O
O	1007	1010	TGF	TGF	NN	B-NP
O	1011	1016	alpha	alpha	SYM	O
O	1017	1027	expression	expression	NN	B-NP
O	1028	1031	was	be	VBD	B-VP
O	1032	1036	also	also	RB	I-VP
O	1037	1046	inhibited	inhibit	VBN	I-VP
O	1046	1047	.	.	.	O

O	1048	1050	It	It	PRP	B-NP
O	1051	1053	is	be	VBZ	B-VP
O	1054	1063	suggested	suggest	VBN	I-VP
O	1064	1068	that	that	IN	B-SBAR
O	1069	1079	inhibition	inhibition	NN	B-NP
O	1080	1082	of	of	IN	B-PP
B-Cancer	1083	1089	tumour	tumour	NN	B-NP
O	1090	1102	angiogenesis	angiogenesis	NN	I-NP
O	1103	1105	by	by	IN	B-PP
O	1106	1113	vitamin	vitamin	NN	B-NP
O	1114	1115	E	E	NN	I-NP
O	1116	1119	may	may	MD	B-VP
O	1120	1122	be	be	VB	I-VP
O	1123	1125	an	an	DT	B-NP
O	1126	1136	additional	additional	JJ	I-NP
O	1137	1146	mechanism	mechanism	NN	I-NP
O	1147	1150	for	for	IN	B-PP
O	1151	1154	the	the	DT	B-NP
B-Cancer	1155	1165	anticancer	anticancer	JJ	I-NP
O	1166	1172	action	action	NN	I-NP
O	1173	1175	of	of	IN	B-PP
O	1176	1183	vitamin	vitamin	NN	B-NP
O	1184	1185	E	E	NN	I-NP
O	1185	1186	.	.	.	O

